COMP and cancer: Patients with tumors expressing COMP in cancer cells had a median OS of 1.2 years compared with 2.6 years for patients with tumors lacking COMP expression in cancer cells (p = 0.013; Fig. 1B), and the corresponding figures for RFS were 1.1 years and 2.1 years, respectively (p = 0.029; Fig. 1C).